Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMACNS trial

10 p | 6 | 3

The PI3K/AKT/mTOR signalling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis

11 p | 7 | 2

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

10 p | 15 | 1

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells

11 p | 7 | 0